Summit Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11/14/2025 | 33.72 M | $696.72 M | 0.00% | 4.54% |
| VANGUARD GROUP INC | 11/07/2025 | 11.38 M | $235.11 M | 31.20% | 1.53% |
| FMR LLC | 11/13/2025 | 8.92 M | $184.24 M | -3.34% | 1.20% |
| BLACKROCK, INC. | 11/12/2025 | 7.36 M | $152.14 M | 7.55% | 0.99% |
| STATE STREET CORP | 11/14/2025 | 6.36 M | $131.44 M | 58.35% | 0.86% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 4.54 M | $93.77 M | 16.23% | 0.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.13 M | $64.74 M | 6.74% | 0.42% |
| MORGAN STANLEY | 11/14/2025 | 1.93 M | $39.81 M | 200.13% | 0.26% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.60 M | $33.50 M | -25.87% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.39 M | $28.75 M | 33.01% | 0.19% |
| APEIRON CAPITAL LTD | 10/28/2025 | 1.31 M | $27.08 M | 9.16% | 0.18% |
| UBS GROUP AG | 11/13/2025 | 1.28 M | $26.42 M | -38.93% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.22 M | $25.17 M | 12.91% | 0.16% |
| ABRDN PLC | 11/07/2025 | 1.14 M | $23.54 M | 0.00% | 0.15% |
| NOMURA HOLDINGS INC | 11/14/2025 | 1.05 M | $21.67 M | 2,286.31% | 0.14% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 900.00 K | $18.59 M | 28.57% | 0.12% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 876.39 K | $18.11 M | -32.15% | 0.12% |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | 11/14/2025 | 817.28 K | $16.88 M | -8.17% | 0.11% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 781.90 K | $16.15 M | -10.10% | 0.11% |
| FIERA CAPITAL CORP | 11/07/2025 | 762.09 K | $15.74 M | -2.65% | 0.10% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 746.39 K | $15.42 M | -25.36% | 0.10% |
| CITADEL ADVISORS LLC | 11/14/2025 | 726.40 K | $15.01 M | 84.51% | 0.10% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 710.00 K | $14.67 M | 0.00% | 0.10% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 657.31 K | $13.58 M | 16.10% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 597.70 K | $12.35 M | -30.75% | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 550.00 K | $11.36 M | 120.00% | 0.07% |
| NORTHERN TRUST CORP | 11/14/2025 | 546.26 K | $11.29 M | 2.75% | 0.07% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 537.53 K | $11.11 M | 11.06% | 0.07% |
| CANDRIAM S.C.A. | 11/06/2025 | 513.76 K | $10.61 M | 0.00% | 0.07% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 497.55 K | $10.28 M | 63.98% | 0.07% |
| CAPRICORN FUND MANAGERS LTD | 10/17/2025 | 496.27 K | $10.25 M | 100.00% | 0.07% |
| BARCLAYS PLC | 11/12/2025 | 475.78 K | $9.83 M | 51.61% | 0.06% |
| INVESCO LTD. | 11/13/2025 | 426.08 K | $8.80 M | 0.48% | 0.06% |
| JANE STREET GROUP, LLC | 11/14/2025 | 409.70 K | $8.46 M | 31.19% | 0.06% |
| LMR PARTNERS LLP | 11/14/2025 | 409.10 K | $8.45 M | 122.58% | 0.06% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 374.58 K | $7.74 M | -1.43% | 0.05% |
| JANE STREET GROUP, LLC | 11/14/2025 | 374.50 K | $7.74 M | 27.55% | 0.05% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 367.13 K | $7.58 M | 6.87% | 0.05% |
| QVT FINANCIAL LP | 11/14/2025 | 360.52 K | $7.45 M | 0.00% | 0.05% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 350.00 K | $7.23 M | 100.00% | 0.05% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2025 | 347.24 K | $7.17 M | 100.00% | 0.05% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/12/2025 | 339.18 K | $7.01 M | 70.57% | 0.05% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 11/07/2025 | 338.36 K | $6.99 M | 409.19% | 0.05% |
| SCULPTOR CAPITAL LP | 11/14/2025 | 333.50 K | $6.89 M | 100.00% | 0.04% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 299.55 K | $6.19 M | 13.62% | 0.04% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 269.88 K | $5.58 M | 0.78% | 0.04% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 264.29 K | $5.46 M | 2.88% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 246.56 K | $5.09 M | -17.81% | 0.03% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 242.62 K | $5.13 M | 67.89% | 0.03% |
| NUVEEN, LLC | 11/12/2025 | 232.64 K | $4.81 M | 28.92% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 291 institutional investors and hedge funds held shares of Summit Therapeutics Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 33.72 M
VANGUARD GROUP INC: 11.38 M
FMR LLC: 8.92 M
BlackRock, Inc.: 7.36 M
STATE STREET CORP: 6.36 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.54 M
13.85% of Summit Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 118.54 M shares in the last 24 months. This purchase volume represents approximately $2.18 B in transactions.